The Lift Line
“Before the camera enters the chemist, the government needs to answer a more fundamental question: Who will be watching the watcher?”
Why This Editorial Matters for Your Exam
Ameer Shahul, author of Vaccine Nation (2025) and The Silent Syndicate, takes a health-regulation proposal and tests it against the right to privacy. It is a model for applying the proportionality test, useful in GS2 and GS4, and pairs with The Hindu’s op-ed today on surveillance as a chain.
GS Paper 2: Health; government policies and interventions; fundamental rights. GS Paper 4: Ethics of surveillance; privacy and dignity.
Background and Context
The proposal. According to the column, the Union Ministry of Health and Family Welfare has begun a process to allow the sale of prescription drugs only under CCTV surveillance across the country by early 2027.
How prescription drugs are regulated.
| Category | Meaning |
|---|---|
| Schedule H | Prescription-only drugs; sold only on a registered medical practitioner’s prescription |
| Schedule H1 | Introduced in 2013: certain antibiotics, anti-TB drugs and habit-forming drugs; pharmacist must keep a separate register (prescriber, patient, drug, quantity) for three years |
| Schedule X | Narcotic and psychotropic substances; stricter records and prescription retention |
The law is the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945, enforced by State drug controllers; the Central Drugs Standard Control Organisation (CDSCO) under the Drugs Controller General of India (DCGI) approves drugs and coordinates.
The privacy yardstick. K.S. Puttaswamy v. Union of India (2017): any intrusion must satisfy legality, a legitimate aim, proportionality (suitability, necessity, balancing) and procedural safeguards. The column invokes exactly these: legality, necessity and proportionality.
The Analysis
1. The benefits are real but narrow. An audit trail helps inspectors act on complaints and track diversion of Schedule H1 and X drugs.
2. A pharmacy is not a shop like any other. A camera records who buys antidepressants, anti-epileptics, HIV medicines, fertility drugs, abortion pills, sexual health medicines, cancer drugs or psychiatric drugs. Face plus time plus medicine is a health profile.
3. Over-inclusive by design. Most prescription sales (antibiotics, antihypertensives, anti-diabetics) are not high-risk transactions. Why film them all?
4. The camera cannot see the fraud. It shows a paper crossing the counter, not whether the prescription is genuine.
5. The footage problem. Who can access it: the drug inspector, the police, other departments? For what purposes? Can it be copied, linked to other databases or run through facial recognition? Will citizens know? Three months of footage could map a person’s health behaviour.
6. Enforce what exists first. Prescription rules, registers, licensing and inspections already exist; the first question is whether they are enforced.
Data and Institutions Vault
Prelims-grade facts:
Drug regulation:
- Drugs and Cosmetics Act, 1940; Drugs Rules, 1945; CDSCO under the Ministry of Health; head: DCGI.
- Schedule H1 (2013): separate sale register kept for 3 years; red-label warning on the pack.
- Schedule X: narcotic and psychotropic drugs; stricter controls.
- Kerala runs Operation AMRITH (2024) against over-the-counter antibiotic sales.
Privacy:
- Puttaswamy (2017): privacy under Article 21; proportionality test.
- DPDP Act, 2023: applies to digital personal data, including health data; no separate “sensitive data” class.
⚠️ Watch the trap: Drug quality and licensing of retail pharmacies are enforced by State drug control departments; the CDSCO approves new drugs and regulates imports and clinical trials. Drug prices are set by the NPPA.
The Debate
For the author’s view. Surveillance of every patient to catch a few rogue pharmacies fails the necessity test; less intrusive tools exist.
The complications. Over-the-counter antibiotic sales drive antimicrobial resistance (AMR), one of India’s gravest health threats, and inspection capacity is thin. A camera is a cheap deterrent, and footage could be protected by design.
The balanced verdict. Use targeted tools first: e-prescriptions verified at the counter, electronic registers for H1 and X drugs, more inspectors and real penalties. If cameras are used, limit them to high-risk sales, with tight access, short retention and no facial recognition.
How to Think About This
Run the four-step test aloud. For any surveillance proposal, ask: Is there a law? Is the aim legitimate? Is it the least intrusive effective means? Do the benefits outweigh the harm to rights? Answers that walk through these steps score well in both GS2 and GS4.
Diagram-in-Words
Takeaway Box
- Proposal: CCTV for prescription drug sales nationwide by early 2027 (as the column reports).
- Author’s objection: records sensitive health data; cannot verify prescriptions.
- Law: Drugs and Cosmetics Act 1940; Schedules H, H1 (2013), X.
- Test: Puttaswamy proportionality; least intrusive means.
- Fix: enforce existing rules; e-prescriptions; narrow, safeguarded use if any.
Sources: The Indian Express, CDSCO, Ministry of Health and Family Welfare
Source: CCTV Is No Cure for Weak Drug Regulation: Cameras at Chemists and the Privacy of Patients — Ujiyari.com | Free UPSC & State PCS Editorial Analysis
